首页> 外文期刊>European review for medical and pharmacological sciences. >Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study
【24h】

Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study

机译:基于姜黄素的补充剂对无骨密度低的无症状患者的影响:初步的24周补充剂研究

获取原文
           

摘要

OBJECTIVE: Osteopenia is a chronic bone condition characterized by decreased calcification, density, or bone mass that, if untreated, can lead to osteoporosis and bone fractures. Although its increasing prevalence, nowadays osteopenia is not adequately prevented and managed. In this study, we evaluated the efficacy, in term of changes in bone density, and safety of an oral formulation based on turmeric phytosome (Meriva?), in subjects suffering from low bone density. PATIENTS AND METHODS: 57 otherwise healthy subjects with low bone density were enrolled in this pilot, supplement study. Informed participants freely decided to follow either a standard management (SM) to control low bone density (control group=28) or SM associated with a curcumin-based oral supplementation (supplement group=29). The bone densities of heel, small finger and upper jaw were evaluated at inclusion and at different time points during the observational period (4, 12 and 24 weeks), in all subjects. RESULTS: The bone density of the heel measured by the Sahara densitometer remarkably improved in the Meriva?-supplemented group, with a significant decrease of ultrasounds transmission values at week 12 (-18.4%) and at week 24 (-21.0%), compared with baseline values. The bone densities of small finger and upper jaw also significantly increased during the study in supplemented subjects, reaching +7.1% and +4.8%, respectively, at week 24, with respect to values at inclusion. Noteworthy, no significant changes of heel, small finger and upper jaw densities were observed in the control group. Last, no safety and tolerability issues were reported during the observational period. CONCLUSIONS: This preliminary study suggests that a curcumin-based supplementation in combination with an appropriate lifestyle could be beneficial in the prevention and management of osteopenia.
机译:目的:骨质减少症是一种慢性骨病,其特征是钙化,密度或骨量降低,如果不治疗,会导致骨质疏松症和骨折。尽管其患病率正在增加,但如今,骨量减少尚未得到充分的预防和控制。在这项研究中,我们从骨密度变化的角度评估了基于姜黄植物体(Meriva?)的口服制剂对低骨密度患者的疗效。患者与方法:57名其他健康状况良好的低骨密度受试者参加了这项试验性补充研究。知情参与者自由决定采用标准管理(SM)来控制低骨密度(对照组= 28)或与基于姜黄素的口服补充剂相关的SM(补充组= 29)。在观察期间(4、12和24周),在所有受试者中评估了足跟,小指和上颌骨的骨密度。结果:在补充了Meriva?的组中,用Sahara密度计测量的脚后跟的骨密度显着提高,与之相比,第12周(-18.4%)和第24周(-21.0%)的超声透射率显着降低。与基线值。在补充对象的研究中,小手指和上颌骨的骨密度也显着增加,相对于包含物的值,在第24周时分别达到+ 7.1%和+ 4.8%。值得注意的是,对照组中的脚后跟,小指和上颚的密度没有明显变化。最后,在观察期内未报告安全性和耐受性问题。结论:这项初步研究表明,以姜黄素为基础的补充剂与适当的生活方式相结合可能对预防和管理骨质减少有帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号